James Byrd is a Cardiology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
24 Frank Lloyd Wright Dr
Ann Arbor, MI 481059484
Telephone
734-998-7400Registry record last updated 13 Oct 2011.
Clinical trials
- Stellate Ganglion Block in Head and Neck Cancer Surgery
Sponsor: Augusta University
- Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery
Sponsor: Augusta University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year20259 payments
- Blue Earth DiagnosticsProgram year20251 payment
- IDORSIA PHARMACEUTICALS US INCProgram year202311 payments$11,060openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.4%Beta blocker15.6%Metoprolol Succinate61%Atenolol17%Carvedilol13%Metoprolol Tartrate9%Part D<11 patientsCalcium channel blocker13.8%Amlodipine Besylate100%Part D≥28 patients+ 11 more classes in this area
Blood & clotting
9.2%Factor Xa inhibitor5.6%Eliquis100%Part D≥11 patientsP2Y12 inhibitor3.6%Clopidogrel54%Prasugrel Hcl46%Part D<11 patientsMetabolism & gastrointestinal
2.9%Potassium supplement1.5%Potassium Chloride100%Part D<11 patientsSGLT2 inhibitor1.4%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Aldosterone and the menopausal transition's increase in blood pressure and cardiovascular risk
University of Michigan at Ann Arbor
FY2026$752,835R01HL164678 - Aldosterone and the menopausal transition's increase in blood pressure and cardiovascular risk
University of Michigan at Ann Arbor
FY2025$768,199R01HL164678 - Aldosterone and the menopausal transition's increase in blood pressure and cardiovascular risk
University of Michigan at Ann Arbor
FY2024$770,042R01HL164678
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”